Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00851929 |
|
Recruitment Status :
Completed
First Posted : February 26, 2009
Last Update Posted : August 2, 2018
|
Sponsor:
Medical University of South Carolina
Collaborator:
Gilead Sciences
Information provided by:
Medical University of South Carolina
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | April 2011 |
| Actual Study Completion Date : | November 2011 |